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Significant insights into disease pathogenesis have
been gleaned from population-level genetic studies;
however, many loci associated with complex genetic
disease contain numerous genes, and phenotypic
associations cannot be assigned unequivocally.
In particular, a gene-dense locus on chromosome
11 (61.5–61.65 Mb) has been associated with inflam-
matory bowel disease, rheumatoid arthritis, and cor-
onary artery disease. Here, we identify TMEM258
within this locus as a central regulator of intestinal
inflammation. Strikingly, Tmem258 haploinsufficient
mice exhibit severe intestinal inflammation in amodel
of colitis. At the mechanistic level, we demonstrate
that TMEM258 is a required component of the oligo-
saccharyltransferase complex and is essential for
N-linked protein glycosylation. Consequently, homo-
zygous deficiency of Tmem258 in colonic organoids
results in unresolved endoplasmic reticulum (ER)
stress culminating in apoptosis. Collectively, our re-
sults demonstrate that TMEM258 is a central medi-
ator of ER quality control and intestinal homeostasis.
INTRODUCTION
Mucosal homeostasis maintains a delicate balance between host
defense against pathogens and tolerance to commensal microor-
ganisms. In the caseof inflammatory bowel disease (IBD), this bal-
ance is disturbed as a result of genetic and environmental factors
that collectively trigger an unrestrained inflammatory response toCell Repor
This is an open access article under the CC BY-Ncommensals (Graham and Xavier, 2013; Khor et al., 2011). While
the etiology of IBD is incompletely understood, significant insights
into its pathophysiology have been ascertained from genome-
wide association studies (GWASs). To date, GWASs have impli-
cated more than 200 loci in IBD (Jostins et al., 2012; Liu et al.,
2015), yetmanyof these loci containmultiple genes that are in link-
age disequilibrium (LD), and conclusive identification of the IBD
risk gene inmost loci has beenchallenging. In a fewnotable exam-
ples, causal variants associatedwith IBD risk have been identified
by GWAS (e.g., NOD2 and ATG16L1) (Huang, 2015). In the vast
majority of IBD loci, more targeted approaches are necessary to
establish causality. Successful approaches include fine mapping
by dense genotyping (Jostins et al., 2012), deep exome seq-
uencing to identify rare coding variants (Beaudoin et al., 2013; Ri-
vas et al., 2011), and integrative functional approaches combining
genotyping and metadata such as epigenetics and expression
quantitative trait loci (eQTL) (Farh et al., 2015; Okada et al., 2014).
Despite successful approaches to finemapping causal variants,
several complex loci associated with IBD remain unresolved. One
such locus on human chromosome 11 (61.5–61.65 Mb) has been
associated with IBD and also phenotypes related to lipid meta-
bolism, coronary artery disease (CAD), and rheumatoid arthritis
(RA) (Ameur et al., 2012; Hester et al., 2014; Jostins et al., 2012;
Liu et al., 2015; Okada et al., 2014). However, it remains unclear
whether these disease phenotypes are controlled by a common
genetic mechanism, or if these phenotypes are mediated by
distinct genes that are in LD within the chromosome 11 locus. In
fact, this locus contains several genes comprising a haplotype
that arose very recently in humanevolution. The derived haplotype
Dhas rapidly become the commonallele inmodern humansand is
associatedwithmore efficient synthesis of long-chain polyunsatu-
rated fatty acids (LC-PUFAs) and increased hepatic expression
of the rate-limiting enzymes in this process (FADS1 and FADS2)ts 17, 2955–2965, December 13, 2016 ª 2016 The Author(s). 2955
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Expression of TMEM258 in Ileal
Biopsies Exceeds All Other Genes in the
Chromosome 11: 61.5–61.65 Locus
(A) Top SNPs from GWAS (Jostins et al., 2012;
Lappalainen et al., 2013; Okada et al., 2014) for
each phenotype mapped as chromosomal loca-
tion versus significance (–Log10 P).
(B) Expression of candidate genes determined
by RNA-seq from ileum biopsies of IBD patients
and controls (Haberman et al., 2014). RPKM,
reads per kilobase per million. Data represent
mean and SD.
(C) The expression of Tmem258 was overlaid on
intestinal single-cell RNA-seq profiles (Gr€un et al.,
2016). Enterocyte, goblet, and Paneth cell markers
were used to construct a t-SNE plot.(Ameur et al., 2012). It has been proposed that haplotype D im-
parted a selective advantage for early humans with limited dietary
intakeofLC-PUFAprecursors (Ameur etal., 2012), but in combina-
tion with a modern high-fat diet, it is associated with increased
proinflammatory lipids (arachidonic acids), risk for CAD (Kwak
et al., 2011; Lappalainen et al., 2013; Li et al., 2013; Martinelli
et al., 2008; Tanaka et al., 2009), and RA (Okada et al., 2014).
Whereas haplotype D is associated with a proinflammatory lipid
profile and RA, it is not associated with IBD. In contrast, the IBD
risk allele tagged by rs174537 is associated with the ancestral
haplotype A and is characterized by lower levels of proinflamma-
toryarachidonicacids (Hesteretal., 2014; Jostinsetal., 2012; Lap-
palainen et al., 2013; Liu et al., 2015; Tanaka et al., 2009). Further-
more, evidence supporting a contribution of LC-PUFAs to IBD is
lacking (Ananthakrishnan et al., 2014; Costea et al., 2014; Guan
et al., 2014). Collectively, these observations reveal the limitations
of genetics in assigning causality of risk loci to specific genes and
highlight the need for a combined functional-genetic approach to
link genes with IBD risk. Here, we provide genetic evidence impli-
catingTMEM258 in IBD riskand functionally identify the role for this
gene in controlling ER stress responses in the colonic epithelium.
RESULTS
Expression of TMEM258 in Ileal Biopsies Exceeds All
Other Genes in the Chromosome 11: 61.5–61.65 Locus
Given the gene-dense landscape of the chromosome 11 (61.5–
61.65 Mb) locus and sparse functional annotation of the genes2956 Cell Reports 17, 2955–2965, December 13, 2016therein, we sought to prioritize candidate
causal genes that contribute to IBD
pathophysiology. First, we compared
the most significant SNPs in the chromo-
some 11 locus and their respective asso-
ciations with three phenotypes: CD risk
(Jostins et al., 2012), RA risk (Okada
et al., 2014), and elevated arachidonic
acid in blood samples (Lappalainen
et al., 2013). For all three phenotypes,
an overlapping set of associated SNPs
span coding regions for TMEM258,
FADS1, and FADS2 (Figure 1A). By inter-rogating expression levels of candidate genes in ileum biopsies
(Haberman et al., 2014), we found that TMEM258was expressed
at dramatically higher levels than all other neighboring genes in
its locus (Figure 1B). Moreover, examination of Tmem258
expression in a published dataset of single-cell transcriptomics
(Gr€un et al., 2016) revealed highest expression in secretory cell
types such as goblet and Paneth cells with slightly lower expres-
sion in absorptive enterocytes (Figure 1C). Given these findings,
we prioritized TMEM258 for deep functional characterization.
TMEM258 Controls the ER Stress Response
TMEM258 encodes a small 76-amino acid protein containing
two predicted transmembrane domains and no additional func-
tional domains that can be readily identified. Nevertheless,
TMEM258 is highly conserved frommammals to flies and worms
and ubiquitously expressed across human tissues (Figures S1A
and S1B). To determine a biological role for TMEM258, we
initially sought to define its function by knockout, so as to then
evaluate the effects of IBD-associated variants on its function.
Thus, we aimed to identify functional pathway-level perturba-
tions after ablating TMEM258 expression. Toward this end, we
knocked down TMEM258 in HeLa cells by means of lentiviral
transduction with small hairpin RNAs (shRNAs) and performed
transcriptomic analyses by RNA sequencing (RNA-seq). Strik-
ingly, TMEM258 knockdown led to significant upregulation of
genes related to glycoprotein modification, chaperone-medi-
ated protein folding, proteostasis, and ER homeostasis (Figures
2A, S1C, and S1D). In light of these findings, we hypothesized
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Figure 2. Knockdown of TMEM258 Induces
ER Stress
(A) TMEM258 was knocked down in HeLa cells
by lentiviral delivery of shRNA. RNA-seq expres-
sion profiles were obtained 5 days after trans-
duction and computationally queried against ER
stress signatures obtained from GEO datasets
(see Experimental Procedures and Results).
(B) Comparison of differentially expressed genes
in HeLa cells upon TMEM258 knockdown or tu-
nicamycin treatment to induce ER stress.
(C) Sensitivity of HeLa cells to tunicamycin was
determined at day 4 after drug treatment. Viability
was measured by Alamar blue fluorescence.
(D) V5-tagged TMEM258 was ectopically ex-
pressed in HeLa cells by lentiviral transduction.
Immunofluorescence imaging was performed by
staining for TMEM258 with anti-V5 antibody (red)
and ER with anti-Calnexin antibody (green). Scale
bar, 10 mm.
See also Figure S1.that TMEM258 regulates ER stress responses. To test this hy-
pothesis, we compared genes upregulated by TMEM258 knock-
down to previously defined ER stress signatures associated with
the transcription factors ATF4, XBP1, and ATF6 (Figure 2A). Pre-
viously published datasets used in Figure 2A are available in
GEO: GSE35681, GSE44951, GSE15759. An unbiased gene
set enrichment analysis revealed statistically significant overlap
between TMEM258 knockdown and the ER stress response
induced by tunicamycin, which inhibits protein glycosylation
(Figure 2B). In fact, genetic knockdown of TMEM258 induced
hypersensitivity to tunicamycin, resulting in cell death (Fig-
ure 2C). Our findings indicate that ER-localized TMEM258 (Fig-
ure 2D) controls ER homeostasis, and its depletion leads to an
unresolved state of pathological ER stress.
TMEM258 Is a Component of the
Oligosaccharyltransferase Complex and Is Required for
N-linked Protein Glycosylation
To gain deeper insight into the role of TMEM258 in controlling ER
stress responses, we devised a proteomic approach to identify
interaction partners by ectopic expression of TMEM258 in twoCell Reportscell lineages, BV-2 macrophages and
BW5147 T lymphocytes (Figure S2; Table
S1). Strikingly, we detected nearly iden-
tical interaction partners for TMEM258
in both cell lines, despite their distinctly
specialized lineages (Figure 3A). More-
over, we identified all known subunits of
the OST complex as TMEM258 interac-
tors (Figures 3A and 3B). In this context,
the OST is strictly required for N-linked
protein glycosylation, wherein it transfers
a 14-sugar oligosaccharide from doli-
chol to asparagine residues on nascently
translated proteins. Thus, N-linked glyco-
sylation facilitates protein folding and
maintains ER quality control. Consistentwith this notion, we found that TMEM258 silencing dramatically
reduced glycoprotein surface content, as determined by reac-
tivity to concanavalin A, a lectin that specifically binds to a-D-
mannosyl and a-D-glucosyl moieties (Figure 3C).
To further define the role for TMEM258 in N-linked glycosyla-
tion, we monitored maturation of the prototypical glycoprotein
basigen (BSG). In control knockdown experiments, nascently
translated BSG was N-glycosylated in the ER and trafficked to
the Golgi apparatus for further glycosylation. These glycosyla-
tion events were reflected as an upshift in gel mobility, which
was reversed by treatment with the endoglycosidase PNGaseF
(Figure 3D). Strikingly, BSG gel mobility in TMEM258 knockdown
samples was equivalent to PNGaseF-treated samples from
control knockdown, indicating that TMEM258 is required for
N-linked glycosylation (Figure 3D). Collectively, these findings
demonstrate that TMEM258 depletion results in defective
N-linked glycosylation, profound ER stress (Figure 2), and per-
turbed ER homeostasis. Thus, N-linked glycosylation is tightly
regulated to maintain ER homeostasis, and TMEM258 expres-
sion levels are a significant factor in governing the efficiency of
glycosylation.17, 2955–2965, December 13, 2016 2957
ConA
C
ou
nt
Unstained
shCtrl
shTMEM258
Components of ER stress
Proteomics: components pulled 
down by V5-TMEM258/C11orf10  
Protein interactions (StringDB)
Protein interactions 
(ORFeome interactome)
Protein interactions (Both)
RPN1
TUSC3
DAD1
STT3B
RPN2
HSPA5
SEL1L
DDOST
MAGT1
STT3A
PDIA3
CANX
MLEC
C11orf10
(TMEM258)
SYVN1
DNAJB9 HERPUD1
Protein N-linked 
glycosylation
(p = 4x10-18)
Response to ER stress
(p = 9x10-6)
0.0
103
0
5.0
10
15
104 105 106 107
0.5
1.0
1.5
TM
E
M
25
8 
re
la
tiv
e 
e x
pr
es
si
on
shCtrl
shTMEM258
D
C
B
A
0.0 0.5 1.0 1.5 2.0 2.5
0
1
2
Log2 average of Rep1 (SCX and LR)
Lo
g2
 a
ve
ra
ge
 o
f R
ep
2 
(S
C
X 
an
d 
LR
)
Rpn1
Rpn2
Canx
Stt3a
Ddost Stt3b
Mlec
Magt1
Dad1
Tmem258
BV-2
Glb1
Lman2
Sec63
0.0 0.5 1.0 1.5 2.0 2.5
0
1
2
Tmem258
Stt3aDdostStt3b Rpn2
Dad1Mlec
Rpn1Canx
Magt1
Tusc3
Log2 average of Rep1 (SCX and LR)
Lo
g2
 a
ve
ra
ge
 o
f R
ep
2 
(S
C
X 
an
d 
LR
) BW5147
Sec63
Glb1
Lman2
-      +
shTMEM258shCtrl
PNGaseF:
WB: BSG
Glycos.
Native
-      +
Figure 3. TMEM258 Interacts with the OST
Complex and Regulates Protein N-linked
Glycosylation
(A) TMEM258 interaction partners were identified
in BV-2 cells (left) and BW5147 cells (right)
expressing V5-tagged TMEM258. High-perfor-
mance liquid chromatography-mass spectrom-
etry was employed to detect proteins after
immunoprecipitation with anti-V5 antibody.
(B) Network analysis integrating TMEM258 inter-
action partners with the OST complex and ER
stress response.
(C) TMEM258 was knocked down in HeLa cells,
and glycoproteins were detected by surface
staining with FITC-labeled concanavalin A (ConA)
followed by FACS.
(D) Measurement of N-linked glycosylation on
the prototypical glycoprotein basigen (BSG) was
monitored by western blot. Where indicated,
samples were deglycosylated with PNGaseF.
Knockdown of TMEM258 in HeLa cells was
verified by qPCR. shCtrl, control shRNA. Data
represent mean and SD.
See also Figure S2.Tmem258 Controls Intestinal Inflammation in Mice
To determine the role of TMEM258 in intestinal inflammation,
we developed a knockout mouse model (Figures S3A and
S3B) with the aim of eliciting ER stress by perturbing N-linked
glycosylation. Whereas haploinsufficient Tmem258+/ mice
were viable and fertile, we did not obtain any homozygous
Tmem258/ mice from multiple breeding pairs, nor did we
detect any signs of fetal resorption in timed matings. Given
that complete deficiency of Tmem258 is early embryonic lethal,
we reasoned that it functions in a fundamental biological pro-
cess that may be revealed in haploinsufficient Tmem258+/
mice. Initially, we confirmed that Tmem258+/ mice were
generally healthy, development of immune cell subsets was
unperturbed, and intestinal barrier function was intact (Figures
S3C–S3F and S4). However, after induction of intestinal inflam-
mation by oral administration of 2.5% dextran sodium sulfate
(DSS), Tmem258+/ mice exhibited accelerated weight loss2958 Cell Reports 17, 2955–2965, December 13, 2016and increased mortality relative to wild-
type (WT) mice (Figure 4A). Additionally,
overall health scores and blinded his-
topathological scoring indicated exac-
erbated disease in Tmem258+/ mice
(Figures 4B, 4C, and S5). While both
groups of mice showed evidence of
crypt ablation and inflammatory infil-
trates, pathological severity was signifi-
cantly elevated in Tmem258+/ mice
(Figures 4C, S5B, and S5C), and the
epithelial healing response was dimin-
ished in Tmem258+/ mice (Figures 4B,
4C, and S5B). Consistent with increased
histopathological metrics of inflamma-
tion, Tmem258+/ mice exhibited a pro-
nounced inflammatory gene expressionsignature, as determined by RNA-seq of colonic tissue (Fig-
ure 4D and Table S2).
Tmem258 Limits ER Stress and Prevents Apoptosis in
Colonic Epithelial Cells
In the context of intestinal pathology, we hypothesized that
TMEM258 plays a central role in secretory cell types that have
a large translational load, such as Paneth cells and goblet cells,
which secrete large quantities of antimicrobial peptides and mu-
cins respectively. In unmanipulated mice, Tmem258 haploinsuf-
ficiency did not induce dramatic ER stress in the colonic epithe-
lium, but after induction of colitis with DSS, we observed clear
evidence of elevated ER stress in Tmem258+/ mice relative
to WT controls. Specifically, Tmem258 haploinsufficiency led
to increased frequencies of epithelial cells that stained posi-
tive for BiP/GRP78 (HSPA5) (Figures 5A and S6), a major tran-
scriptional target of the unfolded protein response that functions
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Figure 4. Tmem258 Haploinsufficiency Exacerbates DSS Colitis
(A) Mice were administered 2.5%DSS in drinking water for 7 days. Mortality was monitored daily. *p < 0.05 Gehan-Breslow-Wilcoxon test (survival). n = 5–6 mice
per genotype for two independent experiments.
(B) At day 8, tissue sections were obtained and stained with hematoxylin and eosin. Arrows, inflammation; bracket, epithelial proliferation; dashed line, crypt
damage. Scale bar, 25 mm.
(C) Additionally, mice were assigned an overall health score (severity) and colon lengths were measured. Data represent mean and SD. *p < 0.05, Students’ t test.
(D) Colon tissuewas obtained at day 8, and transcriptomic profiles weremeasured by RNA-seq. Differentially expressed inflammatory genes in Tmem258+/mice
are displayed.
See also Figures S3–S5.as a chaperone and regulator of ER stress sensors such as IRE1,
PERK, and ATF6. Moreover, we detected a greater frequency
of apoptotic epithelial cells, as assessed by positive staining
for active caspase 3, in Tmem258+/mice compared to controls.
Consistent with the notion that TMEM258 performs a protec-
tive function in the context of ER-stress-mediated apoptosis,
we observed massive crypt ablation and disorganized disper-sion of Ki67-positive proliferating cells in Tmem258+/ mice
(Figure 5A).
To precisely define the impact of Tmem258 deficiency in
colonic epithelial cells, we sought to generate homozygous null
organoid cultures. We hypothesized that complete deficiency
of Tmem258 would result in unresolved ER stress and rapid
apoptosis. Thus, we devised a CRISPR-based approach toCell Reports 17, 2955–2965, December 13, 2016 2959
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Figure 5. TMEM258 Controls ER Stress and Apoptosis in Colonic Epithelium
(A) Mice were administered 2.5%DSS in drinking water for 7 days. Colon tissue was obtained at day 8 and processed for immunofluorescence imaging to detect
the indicated markers. Scale bar, 25 mm.
(B and C) Complete knockout of Tmem258 was achieved by CRISPR targeting in colonic organoids derived from Tmem258+/ mice bred to stop-floxed Cas9-
GFP mice. Simultaneous delivery of Cre recombinase and sgRNA targeting Tmem258 (or control) was achieved by lentiviral transduction. Viable Cas9-GFP cells
were identified by immunofluorescence staining with anti-GFP antibody (B). Scale bar, 25 mm. In addition, percentages of GFP-positive cells were quantified by
FACS (C). Data represent mean + SD.
(D) Sequencing and validation of insertion/deletion mutations in Tmem258 CRISPR organoids. Data represent mean and SD derived from two independent
sgRNAs for exonic regions and two independent sgRNAs for intronic regions of Tmem258.
See also Figure S6.target the remaining Tmem258 allele in heterozygous mice
and used an inducible Cas9-GFP reporter to monitor loss
of GFP-positive cells as a measure of cell death in targeted cells.
Accordingly, we bred Tmem258+/ mice with stop-floxed Cas9-
2A-GFP knockin mice and isolated colonic crypts to derive
spheroid cultures in vitro. We then introduced single guide
RNAs (sgRNAs) targeting Tmem258 exonic (or intronic) se-
quences by transduction with lentiviral particles co-encoding
Cre recombinase. Following Cre-mediated deletion of the stop
codon upstream of Cas9-2A-GFP, inducible expression of
Cas9 and GFP marks cells that have received a sgRNA. Using
this approach, we found that sgRNAs targeting Tmem258 exons
(Tmem258 CRISPR) had fewer viable Cas9-GFP-positive cells
compared to control sgRNAs targeting noncoding intronic re-2960 Cell Reports 17, 2955–2965, December 13, 2016gions of Tmem258 (Ctrl CRISPR) (Figures 5B and 5C). Impor-
tantly, this observation was consistent across two independent
Tmem258 sgRNAs and two independent control sgRNAs. More-
over, lentiviral titers were similar between all sgRNAs, suggest-
ing that Tmem258 CRISPR induces cell death in organoids.
Morphologically, Tmem258 CRISPR organoids contained scat-
tered Cas9-GFP-positive cells within small spheroids that
encapsulated numerous dead cells within the lumen (Figure 5B).
In contrast, control CRISPR organoids appeared healthier and
larger with contiguous Cas9-GFP-positive cells, suggestive of
active proliferation (Figures 5B and 5C). Among Cas9-GFP-
positive cells, insertion/deletion mutations were observed with
both Tmem258 and control CRISPR, but more in-frame muta-
tions were detected in Tmem258 CRISPR (Figure 5D). This
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Figure 6. Increased Expression of TMEM258
Associates with IBD Risk and Impaired
Secretion of Glycoproteins
(A) Exon-level eQTLs for rs174538 (LD with
rs174537 r2 0.86, D0 0.98). Data were derived from
lymphoblasts in the Geuvadis study (Tintle et al.,
2015). Data represent mean and SD.
(B) Coimmunoprecipitation of TMEM258 and the
OST subunit RPN1 after ectopic expression in
HEK293T cells.
(C) Immunoprecipitation of alpha-1 antitrypsin
(a1AT) from culture supernatant shows that ectopic
expression of TMEM258 in HE293T cells leads to
impaired secretion and glycosylation of a1AT.observation suggests that out-of-frame alleles are negatively
selected, consistent with our finding that Tmem258 deletion in-
creases ER stress and cell death in colonic organoids (Figures
5B and 5C).
Increased Expression of TMEM258 Associates with IBD
Risk and Impaired Secretion of Glycoproteins
To determine how genetic variation associated with IBD risk
impacts TMEM258 function, we fine-mapped eQTL signals
within the chromosome 11 (61.5–61.65) locus to determine
the impact of the IBD risk allele for rs174537 on gene expres-
sion. Using the Geuvadis dataset (Tintle et al., 2015), which is
composed of matched genome sequences and transcriptomes
from immortalized lymphoblasts, we found a strong eQTL ef-
fect for rs174538 on TMEM258, wherein the minor allele was
associated with increased expression. Importantly, rs174538
is in LD with the IBD risk SNP rs174537 (r2 0.86, D0 0.98),
and the minor alleles for both SNPs correspond to IBD risk
and increased expression of TMEM258 (Figure 6A). Although
we also observed eQTL effects for rs174538 on other genes
in the locus, these residual effects regressed-out after adjust-
ing for additional eQTLs in the locus. Thus, the dominant IBD
risk SNP (rs174537) significantly increases expression of
TMEM258, whereas the dominant RA SNP decreases expres-
sion of FADS1 (data not shown). Given these findings, we hy-
pothesized that TMEM258 expression above or below optimal
levels may alter the stoichiometry of the OST complex andCell Reporimpair its catalytic assembly or activity.
To identify the OST subunits with which
TMEM258 interacts, we used V5-tagged
TMEM258 as bait in co-immunoprecipita-
tion experiments. Accordingly, we found
that TMEM258 specifically interacts with
RPN1, and co-expression of both pro-
teins elevates their steady state levels
(Figure 6B). Given that RPN1 was previ-
ously shown to interact with the lectin
MLEC and inhibit secretion of glycopro-
teins (Qin et al., 2012), we sought to
determine the impact of elevated expres-
sion of TMEM258 on protein secretion.
Toward this end, we transfected
HEK293T cells with TMEM258 (or GFPcontrol) and monitored secretion of the glycoprotein alpha 1
anti-trypsin. Strikingly, elevated expression of TMEM258
resulted in impaired glycosylation and secretion of this proto-
typical secretory protein (Figure 6C). Taken together with evi-
dence from human IBD genetics, our results suggest that
perturbation of TMEM258 expression profoundly impacts pro-
tein glycosylation and ER stress responses. Moreover, in-
testinal homeostasis is particularly susceptible to perturba-
tion by pathological ER stress resulting from impaired protein
glycosylation.
DISCUSSION
The chromosome 11 (61.5–61.65) locus contains five protein-
coding genes and has been associated with three distinct phe-
notypes: IBD (Jostins et al., 2012), RA (Okada et al., 2014), and
inflammatory lipid synthesis (Lappalainen et al., 2013). Due to a
relatively recent positive selection event acting on the locus,
extensive LD spans the region. One feasible explanation for
this positive selection is that a derived FADS genotype, associ-
atedwith efficient lipid synthesis, provided a selective advantage
to early humans (Ameur et al., 2012). While overwhelming evi-
dence supports the notion that lipid phenotypes are governed
by genetic variants that impact FADS function, positive selection
for FADS genotypesmay have passively selected all genetic var-
iants in LD with FADS, and more importantly, all phenotypes
conferred by those variants. Indeed, the derived haplotype atts 17, 2955–2965, December 13, 2016 2961
this locus is more common than the ancestral haplotype and is
associated with increased levels of serum phospholipids and
arachidonic acid (Ameur et al., 2012; Hester et al., 2014). While
the impact of FADS1 and FADS2 enzymatic function on lipid
metabolism likely contributes to risk for CAD and RA, it is not
clear that this is the case for IBD. In fact, IBD risk is associated
with the ancestral haplotype, whereas RA and CAD are associ-
ated with the derived haplotype. Moreover, we report that the
IBD risk allele marked by rs174537 has a significant eQTL effect
associated with increased expression of TMEM28. In contrast,
the RA risk allele from this locus (rs968567) is associated with
an eQTL effect resulting in decreased expression of FADS1.
Collectively, our findings support the interpretation that IBD
risk is conferred by TMEM258, while RA and lipid phenotypes
are controlled by effects on FADS.
Given that no clear function has yet been attributed to
TMEM258 in vivo, its association with IBD was not immediately
evident. Here, we identify TMEM258 as a central regulator of
intestinal homeostasis and demonstrate its requirement for
efficient N-linked protein glycosylation and protection from ER-
stress-induced apoptosis. During the course of generating the
Tmem258 knockout mouse and preparation of this manuscript,
another report found that TMEM258 interacts with the OST
complex and controls glycosylation (Blomen et al., 2015). Our re-
sults extend these findings and map the interaction between
TMEM258 and the essential OST subunit RPN1. Moreover, we
have generated a mouse knockout model to link TMEM258
function with intestinal homeostasis. Further analysis of human
genetic data indicates that the IBD risk haplotype in the chro-
mosome 11 (61.5–61.65) locus is associated with increased
expression of TMEM258. In this context, ectopic expression
of TMEM258 impairs OST-mediated glycosylation and secre-
tion. As a subunit of the large multi-subunit OST complex,
TMEM258 abundance above or below optimal levels may alter
the stoichiometry of the complex and impair its catalytic assem-
bly or activity. Consequently, our data implicate perturbation in
protein glycosylation in the induction of pathological ER stress
and intestinal inflammation.
The ER stress response is mediated by three interconnected
networks of sensors and effectors. Accumulation of unfolded
proteins in the ER is sensed by the chaperone Bip/Grp78
(HSPA5), which then dissociates from and activates ATF6
(ATF6), IRE1 (ERN1 and 2), and PERK (EIF2AK3). In turn, ATF6
elicits transcriptional activation of the cytoprotective unfolded
protein response. Similarly, IRE1 controls transcription of a sub-
set of unfolded protein response genes by initiating splicing and
activation of the transcription factor XPB1. In contrast, PERK
activation triggers cell death in response to unresolved ER stress
by activating ATF4 and the executioner CHOP (DDIT3). In the
context of pathological ER stress, GWASs and fine mapping
studies have associated IBD with several genes involved in the
ER stress response, such as ATF4 and ERN2 (IRE1-b) (Jostins
et al., 2012). Moreover, hypomorphic variants of XBP1 are sus-
ceptibility factors in Crohn’s disease and ulcerative colitis (Kaser
et al., 2008). In mouse models, conditional deletion of Xbp1 or
Ire1a (Ern1) leads to colitis resulting from excessive ER stress
and apoptosis induced by CHOP (DDIT3) (Kaser et al., 2008;
Zhang et al., 2015). Thus, mounting evidence highlights genes2962 Cell Reports 17, 2955–2965, December 13, 2016and pathways involved in ER homeostasis as critical genetic fac-
tors imparting risk to IBD.
From a broader perspective, the ER stress response has
been proposed to engage in pathway-level interactions with
additional processes underlying IBD pathophysiology. Specif-
ically, a Crohn’s disease risk variant of the autophagy gene
ATG16L1 is associated with elevated ER stress in Paneth cells
and poor prognosis in patients (Deuring et al., 2014). Moreover,
ER stress in goblet cells can be ameliorated by stimulation of
IL10, another IBD-associated gene (Hasnain et al., 2013). With
mounting evidence implicating the ER stress response in several
immunological diseases including arthritis and interstitial lung
disease (Bettigole and Glimcher, 2015; Watkin et al., 2015),
approaches aimed at alleviating pathological ER stress may
represent a therapeutic opportunity in a range of pathological
contexts (Das et al., 2013; Fu et al., 2015).
EXPERIMENTAL PROCEDURES
DSS-Induced Acute Colitis
Mice were given 2.5% (w/v) dextran sulfate sodium (DSS, MP Biomedicals;
MW = 36,000–50,000) dissolved in drinking water for 7 days, after which reg-
ular drinking water was substituted.With the exception of the survival analysis,
mice were euthanized at day 8, and colons were assessed for length and his-
tology. Clinical assessment of DSS-treated mice included daily evaluation of
weight loss, stool consistency, blood in stool, posture, ruffled fur, andmobility.
Each parameter was individually scored (ranging from 0–3) and disease
severity (0–15) was calculated by sum of individual scores.
Histology
The colon was extracted from DSS-treated mice and divided into proximal,
middle, and distal sections, and fixed in 10% formalin. Sections were stained
with H&E, and histologic examination was performed in a blinded fashion using
a modified validated scoring system (Krieglstein et al., 2007). Three indepen-
dent parameters were measured: (1) severity of inflammation, (2) depth of
injury/inflammation, and (3) crypt damage. Each score was multiplied by a
factor reflecting a percentage of the tissue involved, generating a maximum
possible score of 40. The histopathology score was the sum of the scores ob-
tained from the three segments of the colon, yielding a maximum possible
score of 120 (Kabashima et al., 2002). To detect epithelial cell proliferation,
tissues sections were immunostained for Ki-67 and the frequency of Ki-67-
positive epithelial cells was quantitated.
RNA-Seq on Colon Samples
Mice were administered DSS as described above, and RNA was purified from
colon tissue samples by Trizol extraction (Life Technologies). Purified RNAwas
treated with Turbo DNase (Thermo Fisher Scientific) prior to first-strand cDNA
synthesis and template switching with Maxima reverse transcriptase (Thermo
Fisher Scientific). PolydT oligos were appended on the 50 end with sample
barcodes, unique molecular identifier sequences, and a truncated Illumina
adaptor. Template switch oligos were composed of a truncated Illumina
adaptor and three modified ribocytosines at the 30 end. Following reverse tran-
scription, samples were treated with RNaseH (Thermo Fisher Scientific) and
subjected to second-strand cDNA synthesis with NEBnext (NEB). Double-
stranded cDNA (1 ng) was then tagmented with the Nextera XT kit (Illumina)
for 15 min, followed by 12-cycle PCR to generate 30 DGE libraries. Samples
were pooled to a final concentration of 4 nM and sequenced with a 50-cycle
MiSeq kit (Illumina) by paired-end reads of 21 and 40 cycles followed by one
adaptor read.
shRNA Knockdown
HeLa cells (ATCC) were seeded in 24-well plates at 3.4 3 104/300 mL media.
After 24 hr, cells were transduced with 150 mL lentiviral supernatant packaged
in HEK293T cells. The following constructs were used to produce lentiviral
particles: TMEM258-TRCN0000188656, TMEM258-TRCN0000160130, Luc-
TRCN0000072264, and LacZ-TRCN0000072228 (from the Genetic Perturba-
tion Platform, Broad Institute). Three days after transduction, cells were
passaged into 6-well plates, and media was supplemented with puromycin
(InvivoGen) at a concentration of 3 mg/ml. After 2 days in selection, cells
were harvested for analysis.
Immunofluorescence
HeLa cells (ATCC) were transduced with lentivirus for ectopic expression of
TMEM258 appendedwith anN-terminal V5 tag. Cells were seeded onto cover-
slips andallowed toadhere for 30min at 37C.Subsequently, cellswere fixed in
4% paraformaldehyde for 15 min at 37C and stained with mouse monoclonal
anti-V5 (Invitrogen) and rabbit anti-Calnexin (Cell Signaling Technology) diluted
1:250 in staining buffer (3%BSA, 0.1%saponin, PBS). The following secondary
antibodies were used at a 1:1,000 dilution in staining buffer: Alexa Fluor 488
goat anti-mouse immunoglobulinG (IgG) (Life TechnologiesR37121) andAlexa
Fluor594 goat anti-rabbit IgG (Life Technologies A27034). Cells were mounted
in Vectashield medium containing DAPI (Vector Laboratories) and imaged with
a Zeiss Axio A1microscope equipped with 633/1.25 objective. Image acquisi-
tion was performed with the AxioVision (Rel.4.8) software package.
RNA-Seq on HeLa Cells
TMEM258 was knocked down in HeLa cells as described above. Cells were
lysed, and mRNA was purified with polydT microbeads (Dynabeads mRNA
Direct Kit, Invitrogen). First-strand cDNA synthesis with template switching
was performed as described above. Second-strand cDNA was generated by
NEBnext kit (NEB). Double-stranded cDNA (0.5 ng) was then tagmented with
the Nextera XT kit (Illumina) for 12 min, followed by a 12-cycle PCR to amplify
the whole transcriptome. Samples were then pooled to a final concentration of
4 nM and sequenced with a 50-cycle MiSeq kit (Illumina) by paired-end reads
of 30 and 29 cycles followed by two adaptor reads.
Tunicamycin Stress Test
TMEM258 was knocked down in HeLa cells as described above. Cells were
treated with escalating doses of tunicamycin (Sigma Aldrich) for 4 days. Cell
viability was then monitored by Alamar blue reagent (Invitrogen) according
to the manufacturer’s recommendations.
Glycosylation Assays
TMEM258 knockdown was performed in HeLa cells as described above. Cells
were then gently scraped off the plate and washed in serum-free DMEM prior
to lectin staining with 1 mg FITC-concanavalin A (Sigma). All samples were run
on an Accuri C6 flow cytometer (Becton Dickinson) and analyzed with FlowJo
software. In addition, HeLa cells grown to confluency in 6-well plates were
subjected to western blot for the glycoprotein reporter basigen (BSG). Desig-
nated samples were deglycosylated with PNGaseF according to the manufac-
turer’s protocol (NEB). Samples were then resolved by PAGE, andwestern blot
was performed to detect Bsg (anti-CD147, clone EPR4052, Abcam).
Immunoprecipitation
HEK293T cells (ATCC) were transfected with Lipofectamine 2000 (Invitrogen)
as recommended by the manufacturer. The indicated cDNA constructs were
cloned as PCR products into pCMV (Invitrogen) by Gibson assembly. Trans-
fected cells were lysed (1% Triton X-100, PBS [pH 7.4]), and V5-TMEM258
was immunoprecipitated with anti-V5 magnetic agarose beads (MBL Interna-
tional) with rotation at 4C for 4 hr. Samples were then resolved by PAGE, and
western blot was performed with horseradish peroxidase (HRP)-conjugated
anti-FLAG (anti-DYKDDDDK, Cell Signaling Technologies) to detect RPN1-
FLAG. In secretion studies, HEK293T cells were transfected with the in-
dicated cDNA constructs as described above. Secreted alpha 1 anti-trypsin
(SerpinA1-V5) was immunoprecipitated from culture supernatant as described
above. Samples were then resolved by PAGE, and western blot was per-
formed with HRP-conjugated anti-V5 (Sigma Aldrich).
Immunofluorescence on Colon Samples
Colon samples were fixed in 10% formalin, embedded in paraffin, and
sectioned. Rehydration was performed by serial wash steps with Xylene(10 min), 100% ethanol (twice, 20 s), 90% ethanol (20 s), 70% ethanol (20 s),
and water (twice, 20 s). Sections were then bathed in antigen retrieval buffer
(BD Pharmingen, Retrievagen A, 550524, used per manufacturer instructions).
After blocking in IFF (PBS 1% BSA, 2% fetal calf serum [FCS], filtered) for
30 min, sections were stained with the following primary antibodies diluted
in IFF: anti-cleaved caspase 3, anti-Ki67, anti-BiP (all fromCell Signaling Tech-
nology). After staining for 60min at room temperature in a humidified chamber,
sections were washed in PBS and stained as above with Alexa Fluor 488 goat
anti-rabbit IgG (Life Technologies). Sections were mounted in Vectashield me-
dium containing DAPI (Vector Laboratories) and imaged with a Zeiss Axio A1
microscope equipped with 633/1.25 objective. Image acquisition was per-
formed with the AxioVision (Rel.4.8) software package.
Organoids
Procedures for establishing andmaintainingmouse organoids/spheroids were
based on a previously published method (Miyoshi and Stappenbeck, 2013).
The only difference was the addition of Primocin antibiotic (InvivoGen 1:500)
to all organoid media. In brief, crypts were isolated from mouse distal colon
and suspended in Matrigel (BD Biosciences; 15 ml/well). Matrigel mixture
was plated into 48-well tissue culture plates at room temperature. To prevent
crypts from attaching to the plastic, plates were flipped and incubated at 37C
to polymerize theMatrigel. 500 mL of 50%L-WRNCM (Miyoshi et al., 2012) and
fresh primary culturemedia (AdvancedDMEM/F-12 [Invitrogen] supplemented
with 20% fetal bovine serum, 2 mM glutaMAX, 100 units/mL penicillin, and
0.1mg/mL streptomycin), supplemented with 10 mMY-27632 (ROCK inhibitor;
Tocris Bioscience, R&D Systems) and 10 mM SB 431542 (TGFBR1 inhibitor;
Cayman Chemical Company) was added to each well. Organoids were
passaged (1:3) every 1–3 days for 2 weeks up to transduction and every
2–3 days (1:2–1:3) following transduction. We followed the following steps to
obtain single-cell suspensions of organoid cells for flow cytometry, fluores-
cence-activated cell sorting (FACS), and lentivirus transduction: culture media
was removed from organoid/Matrigel well and 500 mL PBS EDTA (0.5 mM
EDTA in PBS) was added to each well. We scratched and suspended the
Matrigel with a 1000 mL pipette. Organoids were spun at 200 3 g for 5 min
and PBS was removed to the level of the Matrigel containing organoids. Orga-
noids were dissociated by incubation in 0.25% (w/v trypsin for 1 min followed
by vigorous pipetting. Trypsin was washed with wash media and cells were
then either transduced or stained for flow cytometry.
Single-cell suspensions of organoids were obtained from two wells of Matri-
gel organoids and plated as one well in infection media (50% L-WRN media in
DMEM/F12 + 10 mMY-27632 + 10 mMSB 431542). 3 mL of each virus (concen-
trated by ultracentrifugation) was added per well (with four wells/virus/mouse)
for a total volume of 250 ml/well. Cells were left to be transduced for 6 hr
at 37C. Organoid suspensions were then washed and replated in Matrigel
(two wells/well transduced).
For FACS sorting, single-cell suspensions were obtained and filtered
(40 mm). DAPI was added just before the sort as a live/dead marker. Cells
were sorted on GFP-positive DAPI-negative into TRIzol (Ambion).
For imaging, organoids were plated on chamber wells (Nunc Lab-Tek II
Chamber slide system) with 50% L-WRN for 1 day and differentiation media
(primary culture media and 5 mM N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester [DAPT]) for 2 days. Organoids were then fixed in
paraformaldehyde (PFA) for 1 hr at 37C. All steps that followed were at
room temperature. The tissue was permeabilized for 30 min in 1% Triton
X-100 in PBS and then blocked for 1 hr at room temperature (2% BSA, 3%
goat serum, 0.2% Triton in PBS). Primary antibodies (rabbit anti-GFP Alexa-
Fluor647 [1:400], Life Technologies) were added to stain overnight in working
buffer (0.2% BSA 0.2% Triton, 0.3% goat serum). Fixed organoids were
washed all day in working buffer and stained overnight in secondary antibodies
plus Hoechst. Organoids were washed four times, and the chamber was
removed. Coverslips were mounted with ProLong Gold Antifade Reagent
(Life Technologies). Organoids were imaged by confocal microscopy using a
403 objective.
CRISPR Design
All sgRNAs were designed for efficacy using sgRNA Designer (Doench et al.,
2014) and for specificity with CCTop (Stemmer et al., 2015). sgRNA sequencesCell Reports 17, 2955–2965, December 13, 2016 2963
were as follows: exon 2 GAAGTACCACAGTCAGGTGA, exon 3 GTAGAGGTG
ACCTCGTAACT, intronic 1 AGGAGGCTGGTGCTGCCCAA, intronic 2 GGTG
GTTCATTGGTATTTGG. Guides were cloned as oligonucleotides into lenti-
CRISPR v2 plasmid (Sanjana et al., 2014) in which spCas9-2A-PAC was
replaced with cDNA encoding Cre recombinase. Genomic sequencing
primers were as follows: forward i5adapter-TTCCTTAGGAGCTCGAAGCC
and reverse i7adapter-GTCTCAATCCCACCTCAAAGGA, forward i5adapter-
CCCCATGAAAGGTAGTCAGAGAC and reverse i7adapter-CCTGTTGATATG
GCTCTACGAGG, forward i5adapter-TTTCCTTTGAGGTGGGATTGAGA and
reverse i7adapter-CAGCTGGGACATGAGCACTT, forward i5adapter-TCCAA
CTTCAAATTTGCTCAGTTTA and reverse i7adapter-TCGCCTCTAGCCTCTA
GTCA. Sequencing was performed with a 150-cycle MiSeq kit (Illumina).
Mice
All animal studies were conducted under protocols approved by the Subcom-
mittee on Research Animal Care at Massachusetts General Hospital.
Tmem258tm1(KOMP)Vlcg knockout mice (KOMP, UC Davis) were generated by
targeting in VGB6 embryonic stem cells derived from C57BL/6NTac mice.
Blastocyst injections were performed by KOMP, UC Davis. Where indicated,
Tmem258+/ mice were bred to Cas9 transgenic knockin mice (Gt(ROSA)
26Sortm1(CAG-cas9*,-EGFP)Fezh) (Platt et al., 2014) obtained from Jackson
Laboratory.
Statistics
Statistical procedures specific for each technology are described in their
respective sections above. For comparisons between two groups, unpaired
Student’s t tests (two-tailed) or non-parametric tests were employed. See
figure legends for additional details.
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